The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2020 | Propensity score-matched analysis of adjuvant chemo after resection of colorectal peritoneal mets
Ignace H.J.T. de Hingh MD, PhD, and Koen Rovers, MD of Catharina Hospital, Eindhoven, The Netherlands, outlines results from a propensity score-matched analysis based on patients in the Dutch Cancer Registry, evaluating the benefit of adjuvant chemotherapy following resection of colorectal peritoneal metastases. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
